A Randomized, Double-Blind, Double-Dummy, Placebo And Active Comparator Controlled 4-Period Cross-Over Study To Assess The Effect Of PF-04531083 On Heat Pain In The UVB-Induced Pain Model In Healthy Volunteers.
Phase of Trial: Phase I
Latest Information Update: 22 Sep 2010
At a glance
- Drugs Oxycodone; PF 4531083
- Indications Acute pain
- Focus Therapeutic Use
- 22 Sep 2010 Actual end date (Sep 2010) added as reported by ClinicalTrials.gov.
- 22 Sep 2010 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 14 Jul 2010 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov.